339 related articles for article (PubMed ID: 10884382)
41. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
42. p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption.
Stewart ZA; Leach SD; Pietenpol JA
Mol Cell Biol; 1999 Jan; 19(1):205-15. PubMed ID: 9858545
[TBL] [Abstract][Full Text] [Related]
43. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
44. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21(Cip1/WAF1).
Gentilini G; Kirschbaum NE; Augustine JA; Aster RH; Visentin GP
Blood; 1999 Jan; 93(1):25-33. PubMed ID: 9864142
[TBL] [Abstract][Full Text] [Related]
46. Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1.
Clark E; Santiago F; Deng L; Chong S; de La Fuente C; Wang L; Fu P; Stein D; Denny T; Lanka V; Mozafari F; Okamoto T; Kashanchi F
J Virol; 2000 Jun; 74(11):5040-52. PubMed ID: 10799578
[TBL] [Abstract][Full Text] [Related]
47. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
Carstens CP; Krämer A; Fahl WE
Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252
[TBL] [Abstract][Full Text] [Related]
48. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
Cariou S; Donovan JC; Flanagan WM; Milic A; Bhattacharya N; Slingerland JM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9042-6. PubMed ID: 10908655
[TBL] [Abstract][Full Text] [Related]
50. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
[TBL] [Abstract][Full Text] [Related]
51. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
Green SL; Freiberg RA; Giaccia AJ
Mol Cell Biol; 2001 Feb; 21(4):1196-206. PubMed ID: 11158306
[TBL] [Abstract][Full Text] [Related]
52. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
53. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
54. Mutant p53 can delay growth arrest and loss of CDK2 activity in senescing human fibroblasts without reducing p21(WAF1) expression.
Wyllie F; Haughton M; Bartek J; Rowson J; Wynford-Thomas D
Exp Cell Res; 2003 May; 285(2):236-42. PubMed ID: 12706118
[TBL] [Abstract][Full Text] [Related]
55. Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1.
Nakanishi M; Robetorye RS; Adami GR; Pereira-Smith OM; Smith JR
EMBO J; 1995 Feb; 14(3):555-63. PubMed ID: 7859744
[TBL] [Abstract][Full Text] [Related]
56. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
57. Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulating p21Cip/WAF1 and down-regulating cyclin E in SK-HEP-1 cells.
Lee KY; Lee YH; Kim SI; Park JH; Lee SK
Anticancer Res; 1997; 17(2A):1067-72. PubMed ID: 9137450
[TBL] [Abstract][Full Text] [Related]
58. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
59. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.
Musgrove EA; Hunter LJ; Lee CS; Swarbrick A; Hui R; Sutherland RL
J Biol Chem; 2001 Dec; 276(50):47675-83. PubMed ID: 11590147
[TBL] [Abstract][Full Text] [Related]
60. Role of p27(Kip1) in human intestinal cell differentiation.
Deschênes C; Vézina A; Beaulieu JF; Rivard N
Gastroenterology; 2001 Feb; 120(2):423-38. PubMed ID: 11159883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
